Meyka Pro banner
Check-Cap Ltd. Ordinary Share

Check-Cap Ltd. Ordinary Share (MBAI) Stock Overview

Explore Check-Cap Ltd. Ordinary Share’s financial performance, market position, analyst ratings, and future outlook.

MBAINASDAQ
HealthcareMedical - Diagnostics & Research
$1.30
$0.15(13.04%)
U.S. Market opens in 13h 59m

Check-Cap Ltd. Ordinary Share (MBAI)

Meyka AI Score

Z

Key Financials

Market Cap9.1M
P/E Ratio1.98
EPS (TTM)$0.67
ROE4.17%
Fundamental Analysis

AI Price Forecasts

1 Month$1.11
3 Months$1.03
1 Year Target$0.76

MBAI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Check-Cap Ltd. Ordinary Share (NASDAQ: MBAI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Check-Cap Ltd. Ordinary Share's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MBAI on the NASDAQ shows an RSI of 60.19, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.76 for the NASDAQ listing.

Key metrics behind Check-Cap Ltd. Ordinary Share's NASDAQ-traded stock include a P/E ratio of 1.98 and a market capitalization of 9.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MBAI on the NASDAQ.

Price Performance (NASDAQ: MBAI)

1-Day Change
13.04%
5-Day Change
21.50%
1-Month Change
12.07%
3-Month Change
-9.09%
6-Month Change
-14.47%
Year-to-Date (YTD) Change
-19.75%
1-Year Change
-2.99%
3-Year Change
-2.99%
5-Year Change
-2.99%
All-Time (Max) Change
-2.99%

Contact Information

+972 4 830 3400
29 Abba Hushi Ave., Isfiya, HA, 3009000

Company Facts

850 Employees
IPO DateMar 4, 2015
CountryIL
Actively Trading

Frequently Asked Questions